<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ojrdrt</journal-id><journal-title-group><journal-title xml:lang="ru">Онкологический журнал: лучевая диагностика, лучевая терапия</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of oncology: diagnostic radiology and radiotherapy</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7593</issn><issn pub-type="epub">2713-167X</issn><publisher><publisher-name>НЕКОММЕРЧЕСКОЕ ПАРТНЕРСТВО «ОБЩЕСТВО ИНТЕРВЕНЦИОННЫХ ОНКОРАДИОЛОГОВ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37174/2587-7593-2020-3-4-94-100</article-id><article-id custom-type="elpub" pub-id-type="custom">ojrdrt-148</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ СЛУЧАИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASES</subject></subj-group></article-categories><title-group><article-title>МРТ в терминах взвешенных по магнитной восприимчивости изображений в дифференциальной диагностике первичной лимфомы центральной нервной системы и анапластической астроцитомы. Клиническое наблюдение</article-title><trans-title-group xml:lang="en"><trans-title>Magnetic Susceptibility MRI in Differential Diagnostics of Primary CNS Lymphoma and Anaplastic Astrocytoma Clinical Observation</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0431-2610</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сашин</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sashin</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сашин Денис Вячеславович — врач‑рентгенолог, аспирант отделения рентгенодиагностического НМИЦ онкологии им. Н.Н. Блохина Минздрава России</p><p>115478, Москва, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>24 Kashirskoye Highway, Moscow, 115478</p></bio><email xlink:type="simple">denchegs70@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3930-5998</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Долгушин</surname><given-names>М. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Dolgushin</surname><given-names>M. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Долгушин Михаил Борисович — доктор медицинских наук, профессор, вице‑президент, директор «Института ядерной медицины» Химки, АО «Медицина»</p><p>115478, Москва, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>24 Kashirskoye Highway, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8347-1243</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Koбякова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kobyakova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Koбякова Екатерина Алексеевна — главный врач НИИ КиЭР, научный сотрудник отделения рентгенодиагностического НМИЦ онкологии им. Н.Н. Блохина Минздрава России</p><p>115478, Москва, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>24 Kashirskoye Highway, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3785-7070</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нечипай</surname><given-names>Э. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nechipay</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нечипай Эмилия Андреевна — кандидат медицинских наук, врач‑рентгенолог, научный сотрудник отделения рентгенодиагностического НМИЦ онкологии им. Н.Н. Блохина Минздрава России</p><p>115478, Москва, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>24 Kashirskoye Highway, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0194-7645</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гаспарян</surname><given-names>Т. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Gasparyan</surname><given-names>T. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гаспарян Тигран Грачикович — кандидат медицинских наук, врач‑нейрохирург отделения нейрохирургического онкологического НМИЦ онкологии им. Н.Н. Блохина Минздрава России</p><p>115478, Москва, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>24 Kashirskoye Highway, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Blokhin National Medical Research Center of Oncology»</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>31</day><month>12</month><year>2020</year></pub-date><volume>3</volume><issue>4</issue><fpage>94</fpage><lpage>100</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сашин Д.В., Долгушин М.Б., Koбякова Е.А., Нечипай Э.А., Гаспарян Т.Г., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Сашин Д.В., Долгушин М.Б., Koбякова Е.А., Нечипай Э.А., Гаспарян Т.Г.</copyright-holder><copyright-holder xml:lang="en">Sashin D.V., Dolgushin M.B., Kobyakova E.A., Nechipay E.A., Gasparyan T.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.oncoradjournal.ru/jour/article/view/148">https://www.oncoradjournal.ru/jour/article/view/148</self-uri><abstract><p>Первичные лимфомы центральной нервной системы (ПЛЦНС) — относительно редко встречающиеся опухоли, как правило, с мультифокальной манифестацией в головном мозге и быстром прогрессировании. В редких случаях удается поставить правильный диагноз методом МРТ, поскольку, например, злокачественные глиомы при использовании рутинных МРТ протоколов могут проявляться схожим паттерном изменений. Представлен клинический случай дополнительной диагностики ПЛЦНС с использованием МРТ в режиме susceptibility weighted imaging (SWI), подтвержденной данными гистологического исследования операционного материала.</p></abstract><trans-abstract xml:lang="en"><p>Primary lymphomas of the central nervous system (PCLCS) are relatively rare tumors, usually having a multifocal manifestation in the brain and rapid progression. It is not always possible to make a correct diagnosis for MRI, since similar radiological manifestations (markers) of this disease, when using routine protocols, MRI can occur, for example, in malignant gliomas. This article presents a clinical case of a refinement diagnosis — PLCNS when using MRI in sequence (SWI), which was confirmed by the data of histological examination of surgical material.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>анапластическая астроцитома</kwd><kwd>первичная лимфома ЦНС</kwd><kwd>лимфома ЦНС</kwd><kwd>МРТ</kwd><kwd>SWI</kwd><kwd>дифференциальная диагностика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glioblastoma</kwd><kwd>primary lymphomas of the central nervous system (PCLCS)</kwd><kwd>neoangiogenesis</kwd><kwd>MRI‑susceptibility weighted imaging</kwd><kwd>differential diagnostics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бублиевский ДВ, Евзиков ГЮ. Первичная лимфома центральной нервной системы: клиника, диагностика, современные подходы к лечению. Нейрохирургия. 2012;12(1):74‑81.</mixed-citation><mixed-citation xml:lang="en">Bublievskii DV, Evzikov GYu. Neurosurgery. 2012;12(1):74‑81. (In Russ.). DOI: 10.17650/1683‑3295‑2012‑12‑1‑74‑81.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Волошин СВ, Криволапов ЮА, Шуваев ВА, Шмидт АВ, Фоминых МС, Потихонова НА и др. Первичная диффузная В-клеточная крупноклеточная лимфома центральной нервной системы: современные представления о патогенезе, диагностике и принципах лечения. Вестник гематологии. 2011; 3:22‑34.</mixed-citation><mixed-citation xml:lang="en">Voloshin SV, Krivolapov YuA, Gubarina NS, Shmidt AV, Fominyh MS, Potihinova NA, et al. Primary B‑cell lymphoma of the central nervous system (PCLCS): modern concepts about pathogenesis, diagnostic and treatment. Messenger of Hematology. 2011;3:22‑34. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ding Y, Xing Z, Liu B, Lin X, Cao D. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging. Brain Behav. 2014;4(6):841‑9. DOI: 10.1002/brb3.288.</mixed-citation><mixed-citation xml:lang="en">Ding Y, Xing Z, Liu B, Lin X, Cao D. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging. Brain Behav. 2014;4(6):841‑9. DOI: 10.1002/brb3.288.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Нечипай ЭА, Долгушин МБ, Пронин ИН, Бекяшев АХ, Кобякова ЕА, Фадеева ЛМ и др. Возможности МР‑динамического контрастирования в дифференциальной диагностике первичных и вторичных опухолей головного мозга. Медицинская визуализация. 2015;(4):18‑30.</mixed-citation><mixed-citation xml:lang="en">Nechipay EA, Dolgushin MB, Pronin IN, Bekyashev AK, Kobyakova EA, Fadeeva LM, et al. DCE MRI in Differential Diagnosis of Primary and Secondary Brain Tumors. Medical Visualization. 2015;(4):18‑ 30. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hayat MA. Tumor of Central Nervous System. Netherlands: Springer, 2011. Vol. 1. 434 p.</mixed-citation><mixed-citation xml:lang="en">Hayat MA. Tumor of Central Nervous System. Netherlands: Springer, 2011. Vol. 1. 434 p.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Акберов РФ, Яминов ИХ, Сафиуллин РР, Пузакин ЕВ. Диагностика опухолей головного мозга: возможности магнитно-резонансной томографии. Практическая медицина. 2011;1(49):54‑7.</mixed-citation><mixed-citation xml:lang="en">Akberov RF, Yaminov IH, Safiullin RR, Puzakin EV. Diagnostics of brain tumors: capabilities of magnetic resonance tomography. Practic Medicine. 2011;1(49):54‑7. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bagley LJ, Grossman RI, Judy KD, Curtis M, Loevner LA, Polansky M, et al. Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology. 1997;202(2):511‑6. DOI: 10.1148/ radiology.202.2.9015082.</mixed-citation><mixed-citation xml:lang="en">Bagley LJ, Grossman RI, Judy KD, Curtis M, Loevner LA, Polansky M, et al. Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology. 1997;202(2):511‑6. DOI: 10.1148/ radiology.202.2.9015082.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY. Semiquantitative assessment of intratumoral susceptibility signals using non‑contrast‑enhanced high-field high‑resolution susceptibility‑weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol. 2009;30(7):1402‑8. DOI: 10.3174/ajnr.A1593.</mixed-citation><mixed-citation xml:lang="en">Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY. Semiquantitative assessment of intratumoral susceptibility signals using non‑contrast‑enhanced high-field high‑resolution susceptibility‑weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol. 2009;30(7):1402‑8. DOI: 10.3174/ajnr.A1593.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Radbruch A, Wiestler B, Kramp L, Lutz K, Bäumer Ph, Weiler M, et al. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging. Eur J Radiol. 2013;82(3):552‑6. DOI: 10.1016/j.ejrad.2012.11.002.</mixed-citation><mixed-citation xml:lang="en">Radbruch A, Wiestler B, Kramp L, Lutz K, Bäumer Ph, Weiler M, et al. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging. Eur J Radiol. 2013;82(3):552‑6. DOI: 10.1016/j.ejrad.2012.11.002.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kickingereder P, Wiestler B, Sahm F, Heiland S, Roethke M, Schlemmer HP, et al. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion‑, perfusion‑, and susceptibility‑weighted MR imaging. Radiology. 2014;272(3):843‑50. DOI: 10.1148/radiol.14132740.</mixed-citation><mixed-citation xml:lang="en">Kickingereder P, Wiestler B, Sahm F, Heiland S, Roethke M, Schlemmer HP, et al. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion‑, perfusion‑, and susceptibility‑weighted MR imaging. Radiology. 2014;272(3):843‑50. DOI: 10.1148/radiol.14132740.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Yangzong Wu, Zhihong Den, Yuanxiang Lin, Accuracy of susceptibility weighted imaging and dynamic susceptibility contrast MRI for differentiating high — grade glioma from primary CNS lymphomas: a meta — analysis. World Neurosurgery. 2018;18:141‑4. DOI:10.1016/j.wneu.2018.01.098.</mixed-citation><mixed-citation xml:lang="en">Yangzong Wu, Zhihong Den, Yuanxiang Lin, Accuracy of susceptibility weighted imaging and dynamic susceptibility contrast MRI for differentiating high — grade glioma from primary CNS lymphomas: a meta — analysis. World Neurosurgery. 2018;18:141‑4. DOI:10.1016/j.wneu.2018.01.098.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kim HS, Jahng GH, Ryu CW, Kim SY. Added value and diagnostic performance of intratumoral sus-ceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol. 2009;30(8):1574‑9. DOI: 10.3174/ajnr.A1635.</mixed-citation><mixed-citation xml:lang="en">Kim HS, Jahng GH, Ryu CW, Kim SY. Added value and diagnostic performance of intratumoral sus-ceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol. 2009;30(8):1574‑9. DOI: 10.3174/ajnr.A1635.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Radbruch A, Wiestler B, Kramp L, Lutz K, Bäumer Ph, Weiler M, et al. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging. Eur J Radiol. 2013;82(3):552‑6. DOI: 10.1016/j.ejrad.2012.11.002</mixed-citation><mixed-citation xml:lang="en">Radbruch A, Wiestler B, Kramp L, Lutz K, Bäumer Ph, Weiler M, et al. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging. Eur J Radiol. 2013;82(3):552‑6. DOI: 10.1016/j.ejrad.2012.11.002</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Aydin O, Buyukkaya R, Hakyemez B. Susceptibility Imaging in Glial Tumor Grading; Using 3 Tesla Magnetic Resonance (MR) System and 32 Channel Head Coil. Pol J Radiol. 2017;82:179‑87. Published 2017 Apr 1. DOI: 10.12659/PJR.900374.</mixed-citation><mixed-citation xml:lang="en">Aydin O, Buyukkaya R, Hakyemez B. Susceptibility Imaging in Glial Tumor Grading; Using 3 Tesla Magnetic Resonance (MR) System and 32 Channel Head Coil. Pol J Radiol. 2017;82:179‑87. Published 2017 Apr 1. DOI: 10.12659/PJR.900374.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Peters S, Knöß N, Wodarg F, Cnyrim C, Jansen O. Glioblastomas vs. lymphomas: more diagnostic certainty by using susceptibility‑weighted imaging (SWI). Rofo. 2012;184(8):713‑8. DOI: 10.1055/s‑0032‑1312862</mixed-citation><mixed-citation xml:lang="en">Peters S, Knöß N, Wodarg F, Cnyrim C, Jansen O. Glioblastomas vs. lymphomas: more diagnostic certainty by using susceptibility‑weighted imaging (SWI). Rofo. 2012;184(8):713‑8. DOI: 10.1055/s‑0032‑1312862</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kickingereder P, Wiestler B, Sahm F, Heiland S, Roethke M, Schlemmer HP, et al. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion‑, perfusion‑, and susceptibility‑weighted MR imaging. Radiology. 2014;272(3):843‑50. DOI: 10.1148/radiol.14132740.</mixed-citation><mixed-citation xml:lang="en">Kickingereder P, Wiestler B, Sahm F, Heiland S, Roethke M, Schlemmer HP, et al. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion‑, perfusion‑, and susceptibility‑weighted MR imaging. Radiology. 2014;272(3):843‑50. DOI: 10.1148/radiol.14132740.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
